Registration - Consultant

Novo Nordisk Canada Inc. / Garry Keller, Consultant

Registration Information

Client name: Novo Nordisk Canada Inc.
Lobbyist name: Garry Keller, Consultant
Initial registration start date: 2022-01-28
Registration status: Inactive
Registration Number: 947116-370999

Associated Communications

Total Number of Communication Reports: 15

Monthly communication reports in the last 6 months: 0

Version 1 of 3 (2022-01-28 to 2023-01-16)

Registration versions:

Version 1 of 3 (2022-01-28 to 2023-01-16)

Lobbying Information

Subject Matters

Aboriginal Affairs
Budget
Economic Development
Health
Industry
Regional Development
Research and Development
Science and Technology

Subject Matter Details

Policies or Program

Discussions with officials with regards to priorities for the implementation of federal diabetes strategy.
Discussions with officials with regards to the establishment of a life sciences strategy in Canada.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Canadian Institutes of Health Research (CIHR)
Finance Canada (FIN)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
101-2476 Argentia Rd.
Mississauga, ON L5N 6M1
Canada

Telephone number: 905-629-4222

Client representative

Beatrice Clerc, President

Parent Company Information

Novo Nordisk A/S
- 2880 Bagsvaerd
  Novo Allé 00000
  Denmark

Coalition Members Information

Novo Nordisk Canada Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Novo Nordisk Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Novo Nordisk Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Garry Keller | Designated public offices held

Business address:
100 Queen Street
Suite 850
Ottawa, ON K1P 1J9
Canada

Telephone number: 613-231-2630

Consultant Firm and Address

Firm: StrategyCorp Inc.

Address:
100 Queen Street
Suite 850
Ottawa, ON K1P 1J9
Canada

Telephone number: 613-231-2630

Novo Nordisk Canada Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Novo Nordisk Canada Inc./	2022-01-28	2023-12-01

Novo Nordisk Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Garry Keller, StrategyCorp Inc. (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-15 of 15

Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Anton LoRi, Stakeholder Relations Advisor | Office of the Leader of the Opposition | House of Commons
- Connor MacDonald, Policy Advisor | Office of the Leader of the Opposition | House of Commons
Subject Matter of the communication: Health, Regional Development, Science and Technology
Communication date: 2023-11-15
Posted date: 2023-12-15
Communication number: 370999-584689 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2023-05-29
Posted date: 2023-06-15
Communication number: 370999-566969 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Poppy Vineberg, Director, Strategic Horizontal Social Policy | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health
Communication date: 2023-02-10
Posted date: 2023-03-15
Communication number: 370999-557149 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Jason Baillargeon, Director | Agriculture and Agri-Food Canada (AAFC)
Subject Matter of the communication: Health
Communication date: 2023-02-10
Posted date: 2023-03-15
Communication number: 370999-557148 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- William Keefe, Senior Policy Advisor | Office of the Minister of Families, Children and Social Development | Employment and Social Development Canada (ESDC)
Subject Matter of the communication: Health
Communication date: 2023-01-20
Posted date: 2023-02-15
Communication number: 370999-554650 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Nathanielle Morin, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-08-19
Posted date: 2022-09-15
Communication number: 370999-540395 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Daniel Saad, Senior Policy Advisor | Prime Minister's Office (PMO)
- Rebecca Caldwell, Senior Policy Advisor | Senior Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-07-15
Posted date: 2022-08-15
Communication number: 370999-538617 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Mark Nafekh, Director General | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
- Barrett Halliday, Director | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
- Michelle Bishop, Senor Policy Analyst | Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-07-14
Posted date: 2022-08-15
Communication number: 370999-538615 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Kathy Thompson, Executive Vice President | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
Communication date: 2022-04-05
Posted date: 2022-05-16
Communication number: 370999-529780 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-03-15
Posted date: 2022-04-16
Communication number: 370999-526926 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Michael Barrett, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-03-10
Posted date: 2022-04-16
Communication number: 370999-525048 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Rouben Khatchadourian, Vice President | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-03-07
Posted date: 2022-04-16
Communication number: 370999-524429 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Carol Hughes, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-02-28
Posted date: 2022-03-15
Communication number: 370999-524428 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Ziad Aboulatif, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-02-15
Posted date: 2022-03-15
Communication number: 370999-523658 View associated registration
Novo Nordisk Canada Inc.
Consultant: Garry Keller

Designated Public Office Holders who participated in the communication:
- Ziad Aboultaif, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2022-02-09
Posted date: 2022-03-15
Communication number: 370999-521889 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Chief of Staff House of Commons, Office of the Leader of the Opposition	November 2015 to June 2017	Not a designated office
Chief of Staff Foreign Affairs Canada, Office of the Minister	May 2011 to March 2015	March 5, 2015
Chief of Staff Privy Council Office, Office of the Government House Leader	August 2010 to May 2011	May 18, 2011
Executive Director House of Commons, Caucus Research Office	September 2009 to August 2010	Not a designated office
Chief of Staff House of Commons, Office of the Chief Government Whip	October 2008 to September 2009	Not a designated office
Director of Communications Office of the Minister, Environment Canada	January 2007 to October 2008	October 30, 2008
Director of Parliamentary Affairs Treasury Board Secretariat, Office of the President	February 2006 to January 2007	Not a designated office
Legislative Assistant House of Commons, Office of the Member of Parliament for St. Albert	July 1997 to December 2005	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Chief of Staff House of Commons, Office of the Leader of the Opposition	November 2015 to June 2017	Not a designated office
Chief of Staff Foreign Affairs Canada, Office of the Minister	May 2011 to March 2015	March 5, 2015
Chief of Staff Privy Council Office, Office of the Government House Leader	August 2010 to May 2011	May 18, 2011
Executive Director House of Commons, Caucus Research Office	September 2009 to August 2010	Not a designated office
Chief of Staff House of Commons, Office of the Chief Government Whip	October 2008 to September 2009	Not a designated office
Director of Communications Office of the Minister, Environment Canada	January 2007 to October 2008	October 30, 2008
Director of Parliamentary Affairs Treasury Board Secretariat, Office of the President	February 2006 to January 2007	Not a designated office
Legislative Assistant House of Commons, Office of the Member of Parliament for St. Albert	July 1997 to December 2005	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Novo Nordisk Canada Inc. / Garry Keller, Consultant

Registration Information

Associated Communications

Version 1 of 3 (2022-01-28 to 2023-01-16)

Version 1 of 3 (2022-01-28 to 2023-01-16)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address